NASDAQ NMS - GLOBAL MARKET · CMND
-0.58% · -$0.0100 · Vol 47.1K
Market closed · last close 4:00 PM ET · price as of 18:26:09 ET
Clearmind Medicine Inc

Clearmind Medicine Inc

Pharmaceuticals
$1.72
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
CMND
Clearmind Medicine Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CMND moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CMND catalysts
About Clearmind Medicine Inc
Pharmaceuticals
Listed since
2021
Employees
2
Country
CA

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.74
Day high
$1.83
Day low
$1.74
Previous close
$1.73
52W high
$476.00
-99.64% from high
52W low
$1.46
0% of range
Market cap
$2.6M
EPS
$-544.7351
Beta
-0.07
Shares out
1.5M
Volume
47.1K
0.15× rel vol
Avg volume
318.6K
VWAP
$1.78
Price history computed in-house
1W
-8.99%
1M
+6.83%
3M
-33.59%
1Y
-99.58%
YTD
-90.50%
SMA 50 $2.10 · below
SMA 200 $24.18 · below
52W position 0%

CMND overview

Veridion Score
45
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CMND.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CMND Form 4 filings
Public disclosures

Congress activity in CMND

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CMND in the cached public ledger.

Federal contracts

CMND contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CMND in this window.
Lobbying spend

CMND lobbying filings, year to date.

Registered lobbying filings matched to Clearmind Medicine Inc.

$320.0K
Refresh interval: 12hSource: LDA disclosure filings
Trade (domestic/foreign)Health IssuesHealth Issues Defense Alcohol and Drug Abuse Veterans
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jul 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Apr 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jan 20, 2026
Loading news for CMND
Analyst ratings
Sovereign unlock shows live analyst consensus for CMND.
Options
Sovereign unlock shows live options positioning for CMND.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.